Cote d'Ivoire vs IDA blend: Prevalence of anemia among women of reproductive age
Cote d'Ivoire
51.4%
in 2023
IDA blend
40.4%
in 2023
Cote d'Ivoire rank
5th
IDA blend rank
5th
Prevalence of anemia among women of reproductive age over time
- Cote d'Ivoire
- IDA blend
How they compare
Cote d'Ivoire currently reports 51.4% against 40.4% in IDA blend, a difference of 11.0%.
That makes Cote d'Ivoire's figure about 1.3 times IDA blend's.
Across all 24 years both countries report, Cote d'Ivoire has been ahead every year.
Cote d'Ivoire ranks 5th and IDA blend ranks 5th of 192 countries.
Cote d'Ivoire has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Cote d'Ivoire | IDA blend | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 53.2% | 41.9% | 11.4% | Cote d'Ivoire |
| 2010s | 49.9% | 41.0% | 8.9% | Cote d'Ivoire |
| 2020s | 50.6% | 40.2% | 10.4% | Cote d'Ivoire |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence of anemia among women of reproductive age, Cote d'Ivoire or IDA blend?
- Cote d'Ivoire, at 51.4% against 40.4% in IDA blend as of 2023.
- What is the difference in prevalence of anemia among women of reproductive age between Cote d'Ivoire and IDA blend?
- 11.0%, with Cote d'Ivoire ahead.
- How many years of comparable data are there for Cote d'Ivoire and IDA blend?
- 24 years are reported by both, from 2000 to 2023.
- How do Cote d'Ivoire and IDA blend rank globally for prevalence of anemia among women of reproductive age?
- Cote d'Ivoire ranks 5th and IDA blend ranks 5th of 192 countries.
- Where does this data come from?
- Global Health Observatory Data Repository/World Health Statistics, World Health Organization (WHO), published as Prevalence of anemia among women of reproductive age (% of women ages 15-49). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Prevalence of anemia among women of reproductive age refers to the combined prevalence of both non-pregnant with haemoglobin levels below 12 g/dL and pregnant women with haemoglobin levels below 11 g/dL.